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Background: The aim of this study was to assess severe maternal morbidity (SMM) and near miss (NM) cases
among adolescent girls and women over 35 years of age in the Brazilian Network for Surveillance of Severe
Maternal Morbidity, using a set of standard criteria, compared to pregnant women aged 20 to 34 years.
Methods: A cross-sectional multicenter study conducted in 27 referral obstetric units in Brazil. All pregnant women
admitted to these centers during a one-year period of prospective surveillance were screened to identify cases of
maternal death (MD), NM and other SMM. Indicators of maternal morbidity and mortality were evaluated for the
three age groups. Sociodemographic, clinical and obstetric characteristics, gestational and perinatal outcomes, main
causes of morbidity and delays in care were also compared. Two multiple analysis models were performed, to
estimate the adjusted prevalence ratio for identified factors that were independently associated with the occurrence
of severe maternal outcome (SMO =MNM +MD).
Results: Among SMM and MD cases identified, the proportion of adolescent girls and older women were 17%
each. The risk of MNM or death was 25% higher among older women. Maternal near miss ratio and maternal
mortality ratios increased with age, but these ratios were also higher among adolescents aged 10 to 14, although
the absolute numbers were low. On multivariate analysis, younger age was not identified as an independent risk
factor for SMO, while this was true for older age (PR 1.25; 1.07-1.45).
Conclusions: SMO was high among women below 14 years of age and increased with age in Brazilian pregnant
women.
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Maternal morbidityBackground
Maternal mortality is a key heath care indicator related
to a country’s level of development. Adolescent girls are
most vulnerable to social maladjustment. This may be the
cause or result of unexpected pregnancies, which increase
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reproduction in any medium, provided the orformal education and are associated with lower adherence
to prenatal care [1]. In a similar fashion, although for dis-
tinct reasons, older pregnant women are also considered
at high risk of obstetric complication due to a higher
prevalence of associated morbid conditions and/or mul-
tiparity [2,3].
The study of maternal death (MD) is fraught with diffi-
culties and therefore, in the past years, women who sur-
vive severe conditions of pregnancy or near-miss (NM)
complications have attracted great interest as a source
of information on processes that can lead to death. Theral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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mentary method to audits and inquiries into MD [4,5].
The investigation of NM events provides important de-
tails on factors that may contribute to both MD and
NM. Knowledge on the prevalence and causes of NM
may indeed constitute a new form of evaluating obstet-
ric care [6,7].
In 2009, the World Health Organization (WHO) de-
fined Maternal Near-Miss as a woman who almost died
but survived a complication that occurred during preg-
nancy, childbirth or within the 42 days following pregnancy
termination. Standardized criteria for NM identification
have been defined, according to organ dysfunction and/
or failure- and the WHO recommends that this ap-
proach should be used to assess quality of obstetric care
[6,8,9]. Clinical signs, laboratory tests and management
interventions were used, aimed at diagnosing organ dys-
function or failure. These criteria were previously vali-
dated in a Brazilian obstetric population [10]. However,
in the published literature a wide variety of criteria used
to identify cases of maternal NM still prevail [11].
Although pregnancy during adolescence is a constant
public health issue, due to the recognized higher risk for
the mother and infant, in addition to the strong bio-
logical, psychological and social impact, maternal death
associated with adolescence is more well-known than
the corresponding morbidity. The risk of maternal death
for women aged 15 to 19 years is twice the risk for women
aged 20 to 24 years. For those aged 10 to 15 years, the risk
of death may be even five-fold higher, compared to women
aged 20 to 24 years [12]. Half of all adolescent births in the
world occur in only seven countries: Bangladesh, Brazil,
Democratic Republic of Congo, Ethiopia, India, Nigeria
and the United States [13]. Apart from the United States,
the remaining six countries still have a high maternal mor-
tality ratio. Furthermore, pregnancies among women aged
over 35 years are increasing worldwide. In Finland, the
rate of old age pregnancy increased from a total of 16.7%
in 1997 to 19.2% in 2007 [14]. Data from the WHO for
developing countries around the world reveal a prevalence
of 10.6% of pregnancies in women aged over 35 years be-
tween 2004 and 2008 [15]. Pregnancies in older women
are also associated with a higher maternal and perinatal
morbidity and mortality, with a greater risk of various
morbid conditions, such as hypertension and diabetes,
anomalous presentation, intrapartum fetal distress, cesarean
delivery and postpartum hemorrhage. In older pregnant
women following delivery, Apgar scores were lower and
there was a higher incidence of low birth weight and pre-
term when compared to younger women [2,3,16,17].
However, information on the occurrence of near-miss
and severe maternal morbidity in both extremes of re-
productive age is scarce. The lack of knowledge consid-
ering the impact of the problem and the existence of anyassociated factors liable to intervention makes it difficult
to improve healthcare and prevent complications in
these age groups. Thus, the aim of the current study is
to explore the characteristics of severe maternal morbid-
ity, with special focus on the extremes of reproductive
age, among women identified in the Brazilian Network
for Surveillance of Severe Maternal Morbidity. Knowledge
of these features may lead to improvement in public pol-
icies and result in better care of women developing severe
maternal morbidity in the extremes of reproductive ages.Methods
Detailed information on the study’s method and proce-
dures were previously published [5,18]. Briefly, this was a
multicenter cross-sectional study, implemented in 27 re-
ferral obstetric units in all geographical regions in Brazil.
From July 2009 to June 2010, a prospective surveillance
was carried out and data was collected to identify cases of
potentially life-threatening maternal conditions (PLTC),
maternal near-miss and maternal death, using the new
WHO’s concept and criteria [8]. The present article refers
to an analysis focused on the occurrence of severe mater-
nal morbidity (SMM= PLTC +MNM+MD) and severe
maternal outcome (SMO =MNM+MD) related to the
extremes of maternal age.
Sample size calculation determined that about 75,000
deliveries should be surveyed to identify around 750
near-miss cases, using an approximate theoretical inci-
dence of 10 near miss cases per 1000 deliveries as basis
for calculation [6].
Maternal age was considered an independent variable
that was categorized into three groups: adolescence (be-
tween 10 and 19 years, with a subgroup aged 10-14 years
and another aged 15-19 years), pregnant women over
age 35 (with a subgroup aged 35-39 years and another
aged 40-49 years), and a reference group, aged between
20 and 34 years. Data concerning sociodemographic
characteristics, obstetric history, previous morbid condi-
tions, prenatal care and obstetric complications were
gathered. The occurrence of potentially life-threatening
conditions (PLTC-hemorrhagic, hypertensive, infectious
and other complications), Maternal Near-Miss (MNM-
clinical/laboratory criteria and management of severity)
and Maternal Death (MD) was assessed, according to
the WHO definition [8], in addition to data on preg-
nancy termination and perinatal results. The occurrence
of delays in obstetric care was also assessed. For this
purpose, specific questions in the questionnaire ad-
dressed delays for women seeking care, for reaching the
health facility and also for obtaining the adequate and
timely treatment for their complications. In addition
specific rules for checking the occurrence of these delays
were developed and systematically used for all cases.
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year prospective surveillance by a research coordinator
in each center. Subsequently, after the data was checked
by the local investigator it was entered and stored in the
platform OpenClinica® version 2.5.5 (Akaza Research,
Waltham, MA, USA). Digital data was stored in a pro-
tected database from a computer accessible from the in-
stitutional website of the coordinating center of the
study. Control of data quality was performed for every
case in each participating center by using local rules and
also in the coordinating center using general rules of
completeness and consistency. Trained personnel from
the coordinating center performed site monitoring visits
for randomly selected cases (around 5% of those identi-
fied), cross-checking local data with the information
already stored in the system. A manual of operation was
developed and used by all of the centers involved in the
study, in order to standardize concepts and data collec-
tion [18].
Sampling design corresponded to a single-stage cluster
sampling, with 27 Primary Sampling Units (PSU), rela-
tive to the 27 centers (hospitals). The sampling design
did not involve PSU stratification or data weighting be-
cause all centers were secondary or tertiary units with
relatively similar teaching hospitals caring for at least
1000 deliveries per year. The unit of analysis was the
medical record of each hospitalized woman with a PLTC
(potentially life-threatening condition), MNM (maternal
near-miss) or MD (maternal death). All variables studied
had relatively low ICC values (intraclass correlation coeffi-
cients), demonstrating the necessary heterogeneity among
study clusters. Specifically for the age variable, the ICC
was 0.013 (95% CI 0.002-0.024) [19].
Data analysis
Data analysis initially consisted of the distribution of
women identified as PLTC, MNM and MD by age
groups, obtaining prevalence ratios (PR) and respective
confidence intervals (95% CI) adjusted by cluster effect
of the study. Age groups were tested as a risk factor for
the occurrence of MNM or MD. Information was not
collected for women without maternal complications
and therefore the distribution of live births for the study
period according to maternal age categories was not
possible. As a proxy, the number of live births (LB) was
estimated according to the number of LB by maternal
age group informed for the country in 2009 [20] so that
health indicators related to maternal morbidity and mor-
tality could be estimated: MNMR (maternal near-miss
ratio per 100,000 LB), SMOR (severe maternal outcome
ratio per 1,000 LB), MMR (maternal mortality ratio per
1,000 LB) and MNM:MD (the ratio between MNM and
MD) [8]. Subsequently, the distributions of variables
relative to socio demographic and clinical characteristics,obstetric history, habits, time and mode of pregnancy
termination, neonatal results, and main causes of severe
maternal morbidity by the three age groups currently
analyzed. The differences between groups were evalu-
ated by the χ2 test.
Finally, Poisson multiple regression analysis was used
to identify factors that were independently and signifi-
cantly associated with the worst outcomes (MD or
MNM), compared to PLTC, for two models. The first
model included only females aged 10 to 34 years (10-19
vs 20-34) for evaluating adolescent pregnant women,
and the second model only women aged 20 to 49 years
(20-34 vs 35-49) for the evaluation of older women.
Women aged 20 to 34 years served as the reference
group category in both models. The estimated coeffi-
cient, standard error (SE) of the coefficient, descriptive
level (p) and prevalence ratio adjusted to cluster effect
and remaining model variables, with their respective
confidence interval (PRadj [95% CI]) were obtained. For
building the models for multiple analyses, all the predict-
ive variables initially entered and then they were manu-
ally selected through the backward criteria in the Stata
software v.7. Statistical analysis was carried out with
software SPSS® version 17.0 (SPSS, Chicago, IL, USA)
and Stata version 7.0 (StataCorp, College Station, Tx,
USA). The descriptive level (α) was preset at 5% (95%
confidence level) and a single-stage conglomerate sam-
pling design was considered.
The study was previously approved by the Institutional
Review Board (IRB of FCM/UNICAMP) of each center and
by the National Research Committee prior to study initiation
on May 5th 2009 (CEP 027/2009). This study did not require
informed consent because data were collected exclusively
from medical records immediately after patient discharge.
Results
During the 12 months of the study, 9555 PLTC, MNM
or MD cases were identified among 82,144 live births
occurring in these hospitals during this period. Adoles-
cents were responsible for 1713 (17.9%) of these cases,
while older women aged 35 to 49 years accounted for a
similar number of cases (1622-17%).
Table 1 shows a 1.25-fold higher risk of maternal near
miss and maternal death for the 35-49 year age group
(PR 1.25, 95% CI: 1.07-1.45), which was even higher in
the 40-49 year age group (PR 1.52, 95% CI: 1.19-1.93).
The prevalence ratio for near miss and maternal death
was not higher for the total number of adolescents, al-
though when ages 10 to 14 years were considered, the
occurrence of 1 maternal death (MD) for every 2.3
MNN cases attracted attention. In the reference group, 1
death occurred (MD) for every 5.1 MNM cases. Table 1
also shows the MNMR and MMR values that increase
with increasing age starting at the 15-19 year group, but
Table 1 Distribution of women by age group and PLTC, MNM and MD
Age (years) % PLTC MNM MD PR (SMO:
MNM+MD)
95% CI ELB MNMR/1000LB SMOR/1000LB MMR/100000 LB MNM:MD
10–19 17.9 18.2 15.2 15.72 0.89 0.77–1.04 16,388 7.14 8.48 134.2 5.3:1
10–14 1.2 1.2 0.9 2.13 0.97 0.57–1.65 797 8.78 12.55 376.4 2.3:1
15–19 16.8 17.0 14.3 13.19 0.88 0.76–1.03 15,591 7.06 8.27 121.9 5.8:1
20–34 65.1 65.3 62.6 67.95 1.00 Ref 57,435 8.39 10.05 165.4 5.1:1
35–49 17.0 16.5 22.2 16.23 1.25 1.07–1.45 8,321 20.55 23.31 276.4 7.4:1
35–39 12.1 11.8 14.8 10.7 1.19 1.00–1.41 6,506 17.52 19.83 230.6 7.6:1
40–49 4.9 4.7 7.4 5.7 1.52 1.19–1.93 1,815 31.40 35.81 440.8 7.1:1
Total 9,555 8,645 770 140 82,144 9.37 11.08 170.4 5.5:1
ELB: estimated live births; LB: number of live births; MD: Maternal Death; MMR: maternal mortality ratio; MNM: Maternal Near Miss; MNM:MD: maternal near miss
to mortality ratio; MNMR: maternal near miss ratio; PLTC: Potentially Life Threatening Condition; SMOR: severe maternal outcome ratio; PR: prevalence ratio.
The number of ELB in each age group was obtained with the number of total live births in the period by age group distribution, according to data from SINASC
(Brazil, 2009).
Maternal near miss ratio (MNMR), severe maternal outcome ratio (SMOR), maternal mortality ratio (MMR) and maternal near miss to mortality ratio (MNM:MD).
Brazil, 2009-2010
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(girls aged 10-14 years).
Table 2 shows the difference between age groups re-
garding sociodemographic characteristics and clinical/
obstetric history. Adolescents had a significantly higher
proportion of non-whites, low school education, lack of
a steady partner, low birthweight and nulliparity (only
12% of these reported having a previous pregnancy). In
contrast, women over 35 years of age, compared to the
reference group, had a higher proportion of low school-
ing, steady relationship, obesity, history of morbid clin-
ical conditions (hypertension, diabetes, heart and thyroid
disease), multiparity, history of previous abortions/cesarean
sections and a lower number of prenatal visits.
In general, adolescents had a better perinatal result
(Table 3). These women had a significantly lower number
of preterm deliveries, cesarean sections and low birth
weight infants, and a higher number of vaginal deliveries,
live births that were discharged in good conditions com-
pared to the control group. In contrast, women over
35 years had a significantly higher number of cesarean
sections and stillbirths than controls.
Inregards to the conditions identified as main causes
of severe morbidity, the only differences found among
the age groups were a lower proportion of hemorrhagic
causes and a higher proportion of hypertensive causes
among adolescent women. Furthermore, adolescents also
had a higher proportion of situations identified as delays
in obtaining adequate care for the complication (Table 4).
The multivariate analyses model, including only ado-
lescents and the reference group, showed that women
with infectious, clinical/surgical and bleeding conditions
(between three and five-fold) and who suffered any delay
in care (two-fold) exhibited a higher risk of having SMO
(MNM and MD). The risk was also higher when there
were preexisting clinical conditions such as diabetes,neoplasm and others, in non-white skin color (between
1.5 and 2-fold). In contrast, obesity decreased by almost
50% the risk of MNM and MD. In this analysis, however,
age was not identified as a factor associated with a worse
case outcome (Table 5).
The same analysis including only women aged 35 or
older and the control group also showed a higher risk of
having SMO (MNM or MD) due to infectious, clinical/
surgical and bleeding conditions, and whether there was
any delay in care (two to five-fold). Among the preexist-
ing clinical conditions, kidney disease, diabetes, thalas-
semia/sickle cell anemia and others, in addition to drug
addiction and having received prenatal care in another
health service, were also greater risk factors for a worse
outcome. It is also observed that previous obesity and
lack of a steady partner were protective factors. Only in
this analysis increased maternal age was shown to sig-
nificantly increase by 25% the risk of a worse outcome
for MNM or MD (Table 6).
Discussion and conclusions
It is well-known that maternal mortality risk is higher in
two periods of age. The first is at the beginning of repro-
ductive life or adolescence, going through a decrease and
stabilization, and increasing again at the end of reproduct-
ive life [21]. The current analysis was carried out to assess
factors that may be associated with a worse outcome of
maternal complications and to evaluate whether the oc-
currence of NM also follows a pattern similar to that of
maternal death regarding female age, in the context of a
national surveillance study of severe maternal morbidity
in Brazil.
The present study showed virtually the same propor-
tion of cases with severe complications in both extremes
of reproductive life (17%), in addition to almost 12% of
repeat pregnancies in adolescence among those with
Table 2 Distribution of women with any severe maternal morbidity by age group according to some characteristics,
clinical and obstetric history
Characteristics 10 – 19 years p* 20 – 34 years p** 35 – 49 years
Ethnicity (non-white) (n) 60.8 (1,259) 0.022 56.9 (4,675) 0.912 56.7 (1,205)
Schooling (up to primary school) (n) 58.0 (1,275) <0.001 41.6 (4,514) <0.001 52.9 (1,134)
Marital status (No steady partner) (n) 62.3 (1,455) <0.001 45.2 (5,255) <0.001 36.6 (1,329)
BMI (n) (630) <0.001 (2,600) 0.014 (704)
Low weight 30.0 13.4 9.8
Adequate 33.8 27.1 24.9
Overweight 19.5 27.7 28.4
Obesity 16.7 31.8 36.9
Previous condition& (n) 29.3 (1,446) <0.001 49.6 (5,363) <0.001 66.1 (1,432)
Hypertension 3.5 <0.001 16.7 <0.001 35.4
Diabetes mellitus 0.6 <0.001 2.2 <0.001 5.7
Cardiac 2.1 0.287 2.7 <0.001 4.7
Thyroid disease 0.6 0.028 1.3 0.010 2.8
Respiratory 3.1 0.458 2.8 0.776 2.7
Nephropathy 0.6 0.061 1.4 0.906 1.4
Thalassemia/sickle cell anemia 0.6 0.148 1.0 0.012 0.3
Collagenosis 0.4 0.539 0.6 0.508 0.5
Neoplasms 0.1 0.119 0.3 0.641 0.4
HIV/AIDS 0.3 <0.001 1.3 0.973 1.3
Low weight 1.0 <0.001 0.2 0.794 0.1
Obesity 12.9 <0.001 25.8 0.033 29.2
Smoking 3.9 0.013 5.9 0.599 6.4
Drug addiction 0.9 0.153 1.3 0.934 1.3
Other 3.4 0.100 4.9 0.003 8.3
Parity (n) (1,707) <0.001 (6,171) <0.001 (1,615)
0 88.2 44.8 18.8
1–2 11.4 43.4 47.8
≥3 0.4 11.7 33.4
Previous abortion 7.3 (1,707) <0.001 22.5 (6,169) <0.001 37.6 (1,615)
Previous Cesarean section 5.6 (1,703) <0.001 25.9 (6,084) <0.001 36.8 (1,572)
Number of prenatal visits (1,334) <0.001 (4,863) 0.086 (1,260)
0 5.4 8.6 10.2
1–5 41.9 37.0 38.5
≥6 52.7 54.4 51.3
*p-values for proportions between adolescent and control groups.
**p-values for proportions between older age and control groups.
&previous conditions are not mutually exclusive.
Brazil, 2009-2010.
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differences between both extremes of age.
Among the total number of adolescents, the risk of
SMO (NM or MD) was not significantly higher. However,
in adolescents up to age 14, the extremely low case/fatality
ratio captures attention. If adolescent pregnancy is already
considered a problem [1], the problem is compoundedespecially in the 10-14 year age group [12]. All unfavorable
conditions are exacerbated: physical, social, economic or
violent incidents. Although the ratio of cases identified in
this specific age group was small (1.2% of the total number
of cases studied), not allowing a deeper analysis, a high
risk was observed, reinforcing the need to expend sus-
tained efforts to avoid pregnancy in this age period [12].
Table 3 Distribution of women with any severe maternal morbidity by age group according to time and mode of
pregnancy termination and neonatal outcomes
Outcomes 10 – 19 years p-value* 20 – 34 years p-value** 35 – 49 years
Preterm birth <37 weeks (a) 36.5 <0.001 47.3 0.116 49.7
(n) (1,510) (5,444) (1,381)
Mode or pregnancy termination (b) <0.001 0.037
Vaginal birth 27.8 21.7 19.6
Cesarean section 62.8 65.1 65.2
Abortion/ectopic 2.7 6.1 7.4
Still pregnant 6.7 7.0 7.8
(n) (1,701) (6,194) (1,619)
Apgar 5th min <7 (c) 3.8 0.768 3.9 0.863 3.8
(n) (1,430) (4,954) (1,241)
Birth weight <2.500 g (d) 32.4 <0.001 41.0 0.274 42.9
(n) (1,468) (5,147) (1,308)
Neonatal condition at birth (e) 0.014 0.019
Live birth 96.8 95.2 93.4
Stillbirth 3.2 4.7 6.6
(n) (1,499) (5,274) (1,348)
Neonatal outcome (f) <0.001 0.370
Discharge 80.4 74.2 75.2
Admitted or transferred 17.3 23.0 22.7
Neonatal death 2.3 2.8 2.1
(n) (1,395) (4,839) (1,212)
(a) 1220 cases excluded (still pregnant, abortion, ectopic pregnancy, or missing GA).
(b) 41 cases excluded (missed information on mode of pregnancy termination).
(c) 1930 cases excluded (still pregnant, abortion, ectopic pregnancy, fetal death, or missing Apgar).
(d) 1632 cases excluded (still pregnant, abortion, ectopic pregnancy, or missing weight).
(e) 1434 cases excluded (still pregnant, abortion, ectopic pregnancy, or missing condition at birth).
(f) 2109 cases excluded (still pregnant, abortion, ectopic pregnancy, or missing neonatal outcome).
*p-values for proportions between adolescent and control groups.
**p-values for proportions between older age and control groups.
Brazil, 2009-2010.
Table 4 Distribution of women with any severe maternal morbidity by age group according to main determining
causes and delays in appropriate care
Main causes of SMM 10 – 19 years p-value* 20 – 34 years p-value** 35 – 49 years
Hemorrhage 19.4 <0.002 24.7 0.837 25.1
Hypertension 73.0 0.009 69.3 0.555 70.6
Infections 1.3 0.177 1.0 0.464 1.1
Clinical surgical conditions 11.0 0.898 10.9 0.457 9.9
(n) (1,713) (6,220) (1,622)
Any delay (a) 57.7 0,002 52.7 0.503 53.9
(n) (1550) (5,686) (1,480)
(a) 839 cases excluded (missing information on delays).
*p-values for proportions between adolescent and control groups.
**p-values for proportions between older age and control groups.
Brazil, 2009-2010.
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Table 5 Conditions independently associated with higher severity (SMO: MNM+MD) among women aged 10 to 19
compared to aged 20 to 34 years [n = 5,350]
Variables Coefficient SE coeff. p PRadj [95% CI]
Infectious conditions 1.66 0.33 <0.001 5.23 [2.64–10.36]
Clinical surgical conditions 1.52 0.16 <0.001 4.58 [3.33–6.31]
Hemorrhagic conditions 1.01 0.28 <0.002 2.75 [1.54–4.89]
Any delay 0.75 0.12 <0.001 2.11 [1.64–2.72]
Another previous condition 0.71 0.11 <0.001 2.03 [1.60–2.57]
Previous condition: diabetes 0.63 0.20 0.003 1.88 [1.26–2.82]
Previous condition: neoplasms 0.53 0.22 0.024 1.71 [1.08–2.69]
Ethnicity (nonwhite) 0.31 0.14 0.041 1.36 [1.01–1.82]
Previous condition: obesity −0.65 0.17 <0.002 0.52 [0.37–0.74]
Constant −3.62 0.21 <0.001
PRadj: prevalence ratio adjusted by cluster effect and also by variables shown to be significant in the final model.
Poisson multiple regression, controlled by: Age 1 (10–19 years: 1/20–34: 0); Ethnicity (Nonwhite: 1/Other: 0); Schooling (up to primary school: 1/Other: 0); Marital
status (no steady partner: 1/Other: 0); BMI (Low weight, adequate: 0/overweight, obesity: 1); Prenatal care at the same service (Absent: 1/Present: 0); Previous
clinical conditions (Yes: 1/No: 0); Chronic hypertension (Yes: 1/No: 0); Obesity (Yes: 1/No: 0); Low weight (Yes: 1/No: 0); Diabetes mellitus (Yes: 1/No: 0); Smoking
(Yes: 1/No: 0); Cardiac diseases (Yes: 1/No: 0); Respiratory diseases (Yes: 1/No: 0); Renal diseases (Yes: 1/No: 0); Thalassemia/sickle cell anemia (Yes: 1/No: 0); HIV/
AIDS (Yes: 1/No: 0); Thyroid diseases (Yes: 1/No: 0); Neurologic diseases/epilepsy (Yes: 1/No: 0); Collagenosis (Yes: 1/No: 0); Neoplasms (Yes: 1/No: 0); Other
preexisting condition (Yes: 1/No: 0); Drug addiction (Yes: 1/No: 0); Parity (0/≥1: 1); Previous abortion (Yes: 1/No: 0); Previous Cesarean section (Yes: 1/No: 0); Time
since last delivery (years); Number of prenatal visits (up to 5: 0/≥6: 1); hemorrhagic conditions (Yes: 1/No: 0); Hypertensive conditions (Yes: 1/No: 0); Infectious
conditions (Yes: 1/No: 0); Clinical surgical conditions (Yes: 1/No: 0); Any delay (Yes: 1/No: 0).
Brazil, 2009-2010.
Table 6 Conditions independently associated with higher severity (SMO: MNM+MD) among women aged 35 to 49
compared to women aged 20 to 34 years [n = 5,331]
Variables Coefficient SE coeff. p PRadj [95% CI]
Infectious conditions 1.55 0.26 <0.001 4.71 [2.75–8.07]
Clinical surgical conditions 1.37 0.19 <0.001 3.94 [2.68–5.80]
Hemorrhagic conditions 1.12 0.26 <0.001 3.06 [1.81–5.18]
Any delay 0.71 0.09 <0.001 2.03 [1.70–2.42]
Another previous condition 0.80 0.12 <0.001 2.23 [1.75–2.84]
Previous condition: renal diseases 0.78 0.22 <0.002 2.17 [1.39–3.40]
Previous condition: diabetes 0.62 0.17 <0.002 1.87 [1.32–2.63]
Thalassemia/sickle cell disease 0.78 0.26 0.006 2.18 [1.28–3.70]
Previous condition: drug addiction 0.40 0.12 0.003 1.49 [1.15–1.92]
Prenatal care in another service 0.25 0.09 0.010 1.28 [1.07–1.53]
Age (35–49 years × 20–34) 0.22 0.08 0.007 1.25 [1.07–1.45]
Previous condition: obesity −0.52 0.14 <0.002 0.59 [0.44–0.80]
Marital status (no steady partner) −0.65 0.14 <0.001 0.52 [0.39–0.69]
Constant −3.51 0.22 <0.001
PRadj: prevalence ratio adjusted by cluster effect and also by variables shown to be significant in the final model.
Multiple Poisson regression, controlled by: Age 2 (35–49 years: 1/ 20–34: 0); Ethnicity (Nonwhite: 1/Other: 0); Schooling (up to primary school: 1/Other: 0); Marital
status (no steady partner: 1/Other: 0); BMI (Low weight, adequate: 0/overweight, obesity: 1); Prenatal care at the same service (Absent: 1/Present: 0); Previous
clinical conditions (Yes: 1/No: 0); Chronic hypertension (Yes: 1/No: 0); Obesity (Yes: 1/No: 0); Low weight (Yes: 1/No: 0); Diabetes mellitus (Yes: 1/No: 0); Smoking
(Yes: 1/No: 0); Cardiac diseases (Yes: 1/No: 0); Respiratory diseases (Yes: 1/No: 0); Renal diseases (Yes: 1/No: 0); Thalassemia/sickle cell anemia (Yes: 1/No: 0); HIV/
AIDS (Yes: 1/No: 0); Thyroid diseases (Yes: 1/No: 0); Neurologic diseases/epilepsy (Yes: 1/No: 0); Collagenosis (Yes: 1/No: 0); Neoplasms (Yes: 1/No: 0); Other
preexisting condition (Yes: 1/No: 0); Drug addiction (Yes: 1/No: 0); Parity (0/≥1: 1); Previous abortion (Yes: 1/No: 0); Previous Cesarean section (Yes: 1/No: 0); Time
since last delivery (years); Number of prenatal visits (up to 5: 0/≥6: 1); hemorrhagic conditions (Yes: 1/No: 0); Hypertensive conditions (Yes: 1/No: 0); Infectious
conditions (Yes: 1/No: 0); Clinical surgical conditions (Yes: 1/No: 0); Any delay (Yes: 1/No: 0).
Brazil, 2009-2010.
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unfavorable outcome was significantly higher than in
the reference population. In the extreme age group
(age > 40 years), this effect was even stronger. These find-
ings have previously been reported by others [2,14,16,17].
Thus, as already known for maternal death [21], in the
present study not only MMR, but also ratios of MNM in-
creased swelled with increasing maternal age, except for
the lower extreme of maternal age, again is in agreement
with other published results [22-24]. The increased rate of
MNM was probably the main finding of this analysis. Ac-
cording to the WHO [9], this indicator gives an estimate
of the need to increment care and resources that are re-
quired to improve the results of obstetric care in certain
regions. The differential gradient observed in different age
groups could then also be used to prioritize investments
and actions in groups identified as having a higher risk of
MNM and MMR.
The comparison between several characteristics among
the three maternal age groups of all women identified as
having severe maternal morbidity in this study showed
well-known differences among these groups, reflecting
some unfavorable conditions for maternity in both ex-
treme age groups, in comparison to an intermediate re-
productive age. Thus, among adolescents with severe
maternal morbidity, the non-white color was most fre-
quent (poverty and greater vulnerability), lack of a steady
partner and lower level of school education [1,12,13].
Adolescents may be at a disadvantage for not achieving
the total number of school years and this inequality in-
creases among non-white racial groups [25]. Similarly,
nulliparity, vaginal delivery, low maternal weight and
hypertension were more common as a cause of morbid-
ity among adolescents. However, contrary to other stud-
ies [12], perinatal results were better in our cohort.
Obesity was significantly higher with increasing age.
This finding confirms that the epidemic of obesity is the
recent reality for the Brazilian population of reproduct-
ive aged women. Despite the lack of weight information
for a large portion of the women in the study, more than
36% were above adequate weight even among adoles-
cents; while 65% of women aged 35 years or older were
overweight or obese. Obesity is not only a problem for
the occurrence of SMM. It is also an issue that may pos-
sibly influence the future quality of life in these women.
Nevertheless, obesity has also been previously identified
as a risk factor for the occurrence of severe maternal
morbidity [22,23]. The majority of preexisting morbid
conditions were more prevalent among older women,
especially hypertension, diabetes, heart and thyroid con-
ditions. These conditions are more common with in-
creasing age, and they have already been identified as
risk factors for the occurrence of severe maternal mor-
bidity [22].Although a series of improvements have occurred in
Brazil in economic, social and health terms in the last de-
cades [26], maternal health is still characterized by rela-
tively elevated mortality and morbidity rates. In addition
to socioeconomic factors, our data highlights that ex-
tremely young and advanced maternal ages are associated
with a higher risk of maternal complications that progress
unfavorably to near-miss or maternal death. Special atten-
tion should be devoted to the provision of health services
both for prenatal care and management during delivery
and postpartum period.
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